[Sentinel lymph node and neoadjuvant therapy in breast cancer].
Unidad de Mama, Hospital Clínic de Barcelona, Barcelona, España. mmunoz@clinic.ub.es
M
M
Muñoz
J
J
Pahisa
F
F
Xavier Caparrós
S
S
Vidal-Sicart
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D016477:Artifacts; D001943:Breast Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery / Q000628:therapy*; D019090:Case Management; D002986:Clinical Trials as Topic; D005260:Female; D005355:Fibrosis; D006801:Humans; D007258:Informed Consent; D008207:Lymphatic Metastasis; D020360:Neoadjuvant Therapy; D009364:Neoplasm Recurrence, Local; D017410:Practice Guidelines as Topic; D011237:Predictive Value of Tests; D012680:Sensitivity and Specificity; D021701:Sentinel Lymph Node Biopsy
D000970:Antineoplastic Agents